113 related articles for article (PubMed ID: 32109844)
21. Subtherapeutic serum quetiapine concentrations after absorption inhibition by binding resins: a case report.
Hoge RH; Arbouw ME; Radstake SD; van Berlo-van de Laar IR
J Clin Pharm Ther; 2015 Jun; 40(3):355-7. PubMed ID: 25808008
[TBL] [Abstract][Full Text] [Related]
22. Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate.
Yasir M; Gaur PK; Puri D; Shehkar P; Kumar SS
Curr Drug Deliv; 2018; 15(6):818-828. PubMed ID: 28545354
[TBL] [Abstract][Full Text] [Related]
23. Time resolved analysis of quetiapine and 7-OH-quetiapine in hair using LC/MS-MS.
Binz TM; Yegles M; Schneider S; Neels H; Crunelle CL
Forensic Sci Int; 2014 Sep; 242():200-203. PubMed ID: 25072665
[TBL] [Abstract][Full Text] [Related]
24. Development of a level A in vitro-in vivo correlation for extended release dosage forms of quetiapine fumarate.
Gonçalves de Lima L; Rossi de Campos D
Drug Res (Stuttg); 2016 May; 66(5):225-9. PubMed ID: 26697891
[TBL] [Abstract][Full Text] [Related]
25. Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration.
Shah B; Khunt D; Misra M; Padh H
Eur J Pharm Sci; 2016 Aug; 91():196-207. PubMed ID: 27174656
[TBL] [Abstract][Full Text] [Related]
26. How long does the pharmacokinetic interaction between carbamazepine and quetiapine last after carbamazepine withdrawal?
Kopecek M; Potmesil P
Neuro Endocrinol Lett; 2017 Dec; 38(7):475-478. PubMed ID: 29369597
[TBL] [Abstract][Full Text] [Related]
27. Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects.
Datto C; Berggren L; Patel JB; Eriksson H
Clin Ther; 2009 Mar; 31(3):492-502. PubMed ID: 19393840
[TBL] [Abstract][Full Text] [Related]
28. Potential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosis.
Li X; Cameron MD
Chem Res Toxicol; 2012 May; 25(5):1004-11. PubMed ID: 22506851
[TBL] [Abstract][Full Text] [Related]
29. The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function.
Aweeka F; Jayesekara D; Horton M; Swan S; Lambrecht L; Wilner KD; Sherwood J; Anziano RJ; Smolarek TA; Turncliff RZ
Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):27S-33S. PubMed ID: 10771451
[TBL] [Abstract][Full Text] [Related]
30. A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
Potkin SG; Preskorn S; Hochfeld M; Meng X
J Clin Psychopharmacol; 2013 Feb; 33(1):3-10. PubMed ID: 23277250
[TBL] [Abstract][Full Text] [Related]
31. Bioequivalence study of a generic quetiapine in healthy male volunteers.
Mahatthanatrakul W; Rattana K; Sriwiriyajan S; Wongnawa M; Ridtitid W
Int J Clin Pharmacol Ther; 2008 Sep; 46(9):489-96. PubMed ID: 18793579
[TBL] [Abstract][Full Text] [Related]
32. Pre-clinical investigation of the modulation of quetiapine plasma pharmacokinetics and tissues biodistribution by lipid-core nanocapsules.
Carreño F; Paese K; Silva CM; Guterres SS; Dalla Costa T
J Pharm Biomed Anal; 2016 Feb; 119():152-8. PubMed ID: 26683988
[TBL] [Abstract][Full Text] [Related]
33. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers.
Estevez-Carrizo FE; Parrillo S; Ercoli MC; Estevez-Parrillo FT
Clin Ther; 2011 Jun; 33(6):738-45. PubMed ID: 21704238
[TBL] [Abstract][Full Text] [Related]
34. A different insight in hair analysis: Simultaneous measurement of antipsychotic drugs and metabolites in the protein and melanin fraction of hair from criminal justice patients.
Ramírez Fernández MDM; Baumgartner WA; Wille SMR; Farabee D; Samyn N; Baumgartner AM
Forensic Sci Int; 2020 Jul; 312():110337. PubMed ID: 32450478
[TBL] [Abstract][Full Text] [Related]
35. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
Potkin SG; Thyrum PT; Alva G; Bera R; Yeh C; Arvanitis LA
J Clin Psychopharmacol; 2002 Apr; 22(2):121-30. PubMed ID: 11910256
[TBL] [Abstract][Full Text] [Related]
36. The Difficult Interpretation of a Hair Test Result from a 32-Month-Old Child: Administration of Propranolol and Quetiapine or Contamination?
Kintz P; Ameline A; Raul JS
J Anal Toxicol; 2020 Oct; 44(7):747-751. PubMed ID: 32382735
[TBL] [Abstract][Full Text] [Related]
37. Combined in vivo metabolic effects of quetiapine and methadone in brain and blood of rats.
Heisel LS; Andersen FD; Joca S; Sørensen LK; Simonsen U; Hasselstrøm JB; Andersen CU; Nielsen KL
Arch Toxicol; 2024 Jan; 98(1):289-301. PubMed ID: 37870577
[TBL] [Abstract][Full Text] [Related]
38. Postmortem Quetiapine Reference Concentrations in Brain and Blood.
Skov L; Johansen SS; Linnet K
J Anal Toxicol; 2015 Sep; 39(7):557-61. PubMed ID: 26159868
[TBL] [Abstract][Full Text] [Related]
39. Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
Leucht S; Crippa A; Siafis S; Patel MX; Orsini N; Davis JM
Am J Psychiatry; 2020 Apr; 177(4):342-353. PubMed ID: 31838873
[TBL] [Abstract][Full Text] [Related]
40. Dosing Recommendations for Quetiapine When Coadministered With HIV Protease Inhibitors.
Sampson MR; Cao KY; Gish PL; Hyon K; Mishra P; Tauber W; Zhao P; Zhou EH; Younis IR
J Clin Pharmacol; 2019 Apr; 59(4):500-509. PubMed ID: 30452774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
